NCT00330265
Unknown
Phase 2
A Prospective, Randomized, Controlled, Unmasked, Multiple Treatment, Multi-Center Clinical Trial to Evaluate the Efficacy and Safety of an Interactive Wound Dressing Containing Cultured Keratinocytes Versus Conventional Wound Therapy for the Treatment of Diabetic Foot Ulcers
KeraCure21 sites in 1 country300 target enrollmentJanuary 2006
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Foot Ulcer
- Sponsor
- KeraCure
- Enrollment
- 300
- Locations
- 21
- Primary Endpoint
- Percent of subjects achieving complete or (100%) study wound closure by week 12 after initial treatment
- Last Updated
- 17 years ago
Overview
Brief Summary
The objective of this study is to determine the safety and effectiveness of a device (the KC-002 interactive wound dressing) in the promotion of healing in diabetic foot ulcers as compared with a conventional wound therapy regimen for subjects with Type 1 or Type 2 diabetes mellitus.
This is a prospective, randomized, multi-center, unmasked, controlled study. All patients will receive care for the diabetic foot ulcer during the study.
Participation in the study is for 24 weeks.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants included in the study must:
- •Have Type 1 or Type 2 diabetes mellitus
- •Have a diabetic foot ulcer on the bottom of the foot or heal which has been present for three (3) weeks but less than two (2) years and is sufficient size to qualify for the study
- •Be able to visit the study doctor regularly for 24 weeks
Exclusion Criteria
- •Participants may not be included if:
- •The diabetic foot ulcer is infected
- •They have poor circulation in their study foot
- •Cannot or will not wear a special boot to take pressure off the study ulcer
- •They have certain other diseases or laboratory values which are not within a specified range
Outcomes
Primary Outcomes
Percent of subjects achieving complete or (100%) study wound closure by week 12 after initial treatment
Time Frame: 12 weeks
Study Sites (21)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or HemorrhagePostpartum HemorrhageImmediate Postpartum HemorrhageHemorrhage, PostpartumNCT06452355KOKO Medical Inc.72
Completed
Not Applicable
IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial InfarctionAcute Myocardial InfarctionCongestive Heart FailureST-Elevation Myocardial InfarctionNCT01226563Bellerophon BCM LLC303
Completed
Phase 3
Methotrexate - Inadequate Response Device Sub-StudyRheumatoid Arthritis (RA)NCT01173120Bristol-Myers Squibb62
Unknown
Not Applicable
Safety and Efficacy Study of the Z-Lig Medical Device Compared to AllograftRuptured Anterior Cruciate LigamentsNCT01245400Aperion Biologics, Inc.60
Completed
Phase 2
MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)Paranoid SchizophreniaNCT00506077Merck Sharp & Dohme LLC55